NCT02816931View on ClinicalTrials.gov

Drug Concentrations in the Treatment of MDR-TB Related to Minimum Inhibitory Concentrations

CompletedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

September 1, 2018

Study Completion Date

June 1, 2020

Conditions
Tuberculosis, Multidrug Resistant
Trial Locations (1)

Unknown

Xiamen Designated TB hospital, Xiamen

All Listed Sponsors
collaborator

Fudan University

OTHER

collaborator

University Medical Center Groningen

OTHER

lead

Karolinska Institutet

OTHER

NCT02816931 - Drug Concentrations in the Treatment of MDR-TB Related to Minimum Inhibitory Concentrations | Biotech Hunter | Biotech Hunter